Figure 1. Colorized scanning electron microscope (SEM) image of a biodegradable drug-eluting coating on a coronary stent. Catheter-based interventions have revolutionized the practice of ...

Cover Story The success of drug-eluting-stent applications has created a wave of interest in coatings for a number of device sectors. But with greater acceptance comes higher expectations for coating ...

Researchers at La Trobe University have built a sensor that mimics the protective surface of gut cells and, in lab tests, ...

The research team has developed a nanostructured antifouling coating that dramatically improves the performance and stability of the electrochemical aptamer-based (E-AB) biosensors used to monitor ...

A spoonful of sugar might actually help the medicine go down, according to recent research from the University of Mississippi. And it could reduce the harmful side effects of cancer treatment. Instead ...

The MarketWatch News Department was not involved in the creation of this content. BANGALORE, India, Jan. 6, 2025 /PRNewswire/ -- Medical Coatings Market is Segmented by Type (Hydrophilic Coatings, ...

Over the past decade, drug-eluting stents (DES) have greatly transformed the field of interventional cardiology. Generally, three components are included in a DES system: a metal stent platform, a ...

Rahul Dhanda is at the helm of a new therapeutics company, Syntis Bio, which launched this week. But for Dhanda, the company got its start 20 years ago, when he sent a cold email to Bob Langer, PhD, ...

Invetech, a leader in instrument development, custom automation, and contract manufacturing, and Vaxxas, a biotechnology start-up and developer of the Nanopatch™ needle-free drug delivery technology, ...

Arizona State University researchers have established a thermodynamic framework that links water adsorption on coated ...

In a lab study, a combo of anti-aging drugs appeared to cause a profound loss of the protective coating myelin, which is a ...

NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has begun enrolling patients in the Virtue SAB in the Treatment of Coronary ISR Trial, a U.S. IDE pivotal study comparing the company’s ...